Abstract
Although invasive mechanical ventilation (IMV) is an effective technique for supporting alveolar ventilation, it has many associated complications. In intensive care unit (ICU) patients, nosocomial infections are major causes of mortality and morbitidy. The use of invasive devices such as the endotracheal tube is the most important factor for producing nosocomial infections [1]. Ventilator-associated pneumonia (VAP)—defined as the development of parenchymal lung infection after at least 48 h of IMV—is the most common nosocomial infection in the ICU. It is associated with prolonged hospitalization, increased health care costs, and mortality. The incidence of VAP ranges from 6 to 52 %. The risk increases at a rate of 1–3 % for each day that a patient is on IMV. The main pathogenic mechanism for the development of VAP is aspiration of colonized oropharyngeal secretions at the time of intubation or throughout the period on IMV. The risk factors for VAP are shown in Table 31.1.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baudry T, Ader F. Non-invasive mechanical ventilation to prevent ICU-acquired infection. Infect Disord Dryg Targets. 2011;11:384–8.
Girou E, Brun-Buisson C, Taille S, et al. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA. 2003;290:2985–91.
Hess DR. Noninvasive positive-pressure ventilation and ventilator-associated pneumonia. Respir Care. 2005;50:924–9.
Ferrer M, Esquinas A, Arancibia F, et al. Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med. 2003;168:70–6.
Nava S, Ambrosino N, Clini E, et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med. 1998;128:721–8.
Chen J, Qui D, Tao D. Time for extubation and sequential noninvasive mechanical ventilation in COPD patients with exacerbated respiratory failure who received invasive ventilation. Zhonghua Jie He He Hu Xi Za Zhi. 2001;24:99–100.
Ciledag A, Kaya A, Akdogan BB, et al. Early use of noninvasive mechanical ventilation in patients with acute hypercapnic respiratory failure in a respiratory ward: a prospective study. Arch Bronconeumol. 2010;46:538–42.
Wood KA, Lewis L, Von Harz B, et al. The use of noninvasive positive pressure ventilationi in emergency department. Chest. 1998;113:1339–46.
Poponick JM, Renston JP, Bennett RP, et al. Use of a ventilatory support system (BIPAP) for acute respiratory failure in the emergency department. Chest. 1999;116:166–71.
Plant PK, Owen JL, Eliot MW. A multicentre randomised controlled trial of the early use of non-invasive ventilation in acute exacerbation of chronic obstructive pulmonary disease on general respiratory wards. Lancet. 2000;335:1931–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Çiledağ, A., Kaya, A. (2014). Noninvasive Mechanical Ventilation to Prevent Intensive Care Unit-Acquired Infection. In: Esquinas, A. (eds) Noninvasive Ventilation in High-Risk Infections and Mass Casualty Events. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1496-4_31
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1496-4_31
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1495-7
Online ISBN: 978-3-7091-1496-4
eBook Packages: MedicineMedicine (R0)